Mogens T. Stender - Search Results

Year	Number of Results
2008	1
2009	2
2010	1
2014	1
2015	1
2016	1
2017	1
2018	1
2019	2
2020	2
2021	3
2022	0

1

Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.

Ludvigsen M, Thorlacius-Ussing L, Vorum H, Stender MT, Thorlacius-Ussing O, Honoré B. Ludvigsen M, et al. Curr Issues Mol Biol. 2021 Sep 2;43(2):1043-1056. doi: 10.3390/cimb43020074. Curr Issues Mol Biol. 2021. PMID: 34563043 Free PMC article.

2

Irreversible electroporation of pancreatic cancer - Effect on quality of life and pain perception.

Flak RV, Malmberg MM, Stender MT, Hauberg A, Thorlacius-Ussing O. Flak RV, et al. Pancreatology. 2021 May 5:S1424-3903(21)00150-2. doi: 10.1016/j.pan.2021.04.011. Online ahead of print. Pancreatology. 2021. PMID: 33985915

3

Imaging response evaluation after local ablative treatments in locally advanced pancreatic cancer: an expedited systematic review.

Flak RV, Stender MT, Stenholt L, Thorlacius-Ussing O, Petersen LJ. Flak RV, et al. Among authors: stender mt. HPB (Oxford). 2020 Aug;22(8):1083-1091. doi: 10.1016/j.hpb.2020.04.011. Epub 2020 May 22. HPB (Oxford). 2020. PMID: 32451236 Free article. Review.

4

Validating registry data on statins prescriptions by blood measurements.

Riis AH, Erichsen R, Ostenfeld EB, Højskov CS, Thorlacius-Ussing O, Stender MT, Lash TL, Møller HJ. Riis AH, et al. Pharmacoepidemiol Drug Saf. 2019 May;28(5):609-615. doi: 10.1002/pds.4700. Epub 2019 Feb 19. Pharmacoepidemiol Drug Saf. 2019. PMID: 30779395

5

Usefulness of Imaging Response Assessment after Irreversible Electroporation of Localized Pancreatic Cancer-Results from a Prospective Cohort.

Flak RV, Fisker RV, Bruun NH, Stender MT, Thorlacius-Ussing O, Petersen LJ. Flak RV, et al. Among authors: stender mt. Cancers (Basel). 2021 Jun 8;13(12):2862. doi: 10.3390/cancers13122862. Cancers (Basel). 2021. PMID: 34201272 Free PMC article.

6

[Splenic injury after sigmoidoscopy].

Afshari K, Stender MT, Thorlacius-Ussing O. Afshari K, et al. Ugeskr Laeger. 2015 Jan 26;177(2A):64-5. Ugeskr Laeger. 2015. PMID: 25612971 Free article. Danish.

7

The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer.

Rasmussen SL, Krarup HB, Sunesen KG, Johansen MB, Stender MT, Pedersen IS, Madsen PH, Thorlacius-Ussing O. Rasmussen SL, et al. Oncotarget. 2018 Jan 9;9(6):7010-7022. doi: 10.18632/oncotarget.24097. eCollection 2018 Jan 23. Oncotarget. 2018. PMID: 29467946 Free PMC article.

8

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.

Rasmussen SL, Krarup HB, Sunesen KG, Johansen MB, Stender MT, Pedersen IS, Madsen PH, Thorlacius-Ussing O. Rasmussen SL, et al. PLoS One. 2017 Jul 10;12(7):e0180809. doi: 10.1371/journal.pone.0180809. eCollection 2017. PLoS One. 2017. PMID: 28700744 Free PMC article.

9

Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.

Ludvigsen M, Thorlacius-Ussing L, Vorum H, Moyer MP, Stender MT, Thorlacius-Ussing O, Honoré B. Ludvigsen M, et al. Int J Mol Sci. 2020 May 14;21(10):3466. doi: 10.3390/ijms21103466. Int J Mol Sci. 2020. PMID: 32422974 Free PMC article.

10

D-Dimer predicts prognosis and non-resectability in patients with pancreatic cancer: a prospective cohort study.

Stender MT, Larsen AC, Sall M, Thorlacius-Ussing O. Stender MT, et al. Blood Coagul Fibrinolysis. 2016 Jul;27(5):597-601. doi: 10.1097/MBC.0000000000000559. Blood Coagul Fibrinolysis. 2016. PMID: 27182687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results